Hum. Reprod. Advance Access originally published online on November 26, 2004
Human Reproduction 2005 20(2):320-322; doi:10.1093/humrep/deh613
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Can we eliminate severe ovarian hyperstimulation syndrome?
Department of Obstetrics and Gynecology, Rabin Medical Center, Petah Tiqva 49 100 and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Email: orvieto{at}clalit.org.il
The desire of some couples for children is so strong that they are willing to accept a modicum of risk to treat their infertility. Ideally, assisted reproduction technology practitioners seek a balance between optimum ovarian stimulation and successful treatment outcome with minimal rate of severe ovarian hyperstimulation syndrome (OHSS) or multiple pregnancies. However, despite many years of clinical experience, there are no precise methods to completely prevent severe OHSS, except by withholding the ovulation-inducing trigger of hCG. Individualization of treatment according to the specific risk factor and the specific response in the current cycle with the option of freezing of all embryos, or replacement of only a single embryo, has the potential of reducing the risk and the severity of the syndrome in susceptible cases. We offer a triage aimed at eliminating the occurrence of severe ovarian hyperstimulation syndrome on the basis of several clinical observations, including the role of GnRH antagonist in controlled ovarian stimulation protocols, the option of freezing of all embryos, or replacement of only a single embryo in the blastocyst stage.
Key words: controlled ovarian stimulation/ovarian hyperstimulation syndrome/prevention
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Humaidan, E.G. Papanikolaou, and B.C. Tarlatzis GnRHa to trigger final oocyte maturation: a time to reconsider Hum. Reprod., October 1, 2009; 24(10): 2389 - 2394. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Stanek, S. M. Borman, T. A. Molskness, J. M. Larson, R. L. Stouffer, and P. E. Patton Insulin and Insulin-Like Growth Factor Stimulation of Vascular Endothelial Growth Factor Production by Luteinized Granulosa Cells: Comparison between Polycystic Ovarian Syndrome (PCOS) and Non-PCOS Women J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2726 - 2733. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Groten, H.M. Fraser, W.C. Duncan, R. Konrad, R. Kreienberg, and C. Wulff Cell junctional proteins in the human corpus luteum: changes during the normal cycle and after HCG treatment Hum. Reprod., December 1, 2006; 21(12): 3096 - 3102. [Abstract] [Full Text] [PDF] |
||||
![]() |
U.-H. Stenman, A. Tiitinen, H. Alfthan, and L. Valmu The classification, functions and clinical use of different isoforms of HCG Hum. Reprod. Update, November 1, 2006; 12(6): 769 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pau, I. Alonso-Muriel, R. Gomez, E. Novella, A. Ruiz, J. A. Garcia-Velasco, C. Simon, and A. Pellicer Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome Hum. Reprod., June 1, 2006; 21(6): 1453 - 1460. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Griesinger, K. Diedrich, P. Devroey, and E.M. Kolibianakis Reply: Agonist trigger in the context of OHSS prevention: primum non nocere Hum. Reprod. Update, May 1, 2006; 12(3): 328 - 329. [Full Text] [PDF] |
||||
![]() |
G. Griesinger, K. Diedrich, P. Devroey, and E.M. Kolibianakis GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis Hum. Reprod. Update, March 1, 2006; 12(2): 159 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Buckett, R.-C. Chian, and S. L. Tan Can we eliminate severe ovarian hyperstimulation syndrome? Not completely Hum. Reprod., August 1, 2005; 20(8): 2367 - 2367. [Full Text] [PDF] |
||||
![]() |
M. Manno Can we eliminate severe ovarian hyperstimulation syndrome? Comment I Hum. Reprod., August 1, 2005; 20(8): 2368 - 2369. [Full Text] [PDF] |
||||
![]() |
D. De Neubourg and J. Gerris Can we eliminate severe ovarian hyperstimulation syndrome? Comment 2 Hum. Reprod., August 1, 2005; 20(8): 2369 - 2369. [Full Text] [PDF] |
||||
![]() |
R. Orvieto Reply: Can we eliminate severe ovarian hyperstimulation syndrome? Hum. Reprod., August 1, 2005; 20(8): 2367 - 2368. [Full Text] [PDF] |
||||
![]() |
R. Orvieto Replies: Can we eliminate severe ovarian hyperstimulation syndrome. Comments 1 and 2 Hum. Reprod., August 1, 2005; 20(8): 2369 - 2370. [Full Text] [PDF] |
||||


